nected to an outflow cannula. Blood flow is generated in either a pulsatile or continuous flow, depending on the specific device, and circulatory support can be provided with a left ventricular assist device (LVAD), right ventricular assist device (RVAD), or biventricular assist device (BiVAD). Three categories of MCS patients have be described [5] : 1) individuals who require temporary circulatory support who are expected to recover after cardiac injury and will not need HT (bridge to recovery); 2) patients awaiting HT but who would not survive the wait until an organ is available owing to low cardiac output and/or noncardiac comorbidities (bridge to transplantation); 3) individuals who need long-term support but have a relative or absolute contraindication to HT (destination therapy, DT). The 3 rd Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS) Annual Report [6] has documented a transition from pulsatile-flow to continuous-flow pumps, and an increase of patients implanted as DT, associated with an improvement in medium-term survival.
Summary remarks: at present, it seems realistic that MCS will become an alternative to HT, but one of the prerequisites for permanent or semi-permanent VAD use is that exercise performance, although not normal, must be adequate for daily life activities: for this reason, cardiologists in charge of MCS patients must well trained in exercise physiology, exercise testing, and exercise training.
Exercise hemodynamics
LVAD recipients demonstrate improvement in exercise tolerance, non-cardiac organ function, as well as metabolic and neurohormonal levels [7] [8] [9] . The positive effects of LVAD on left ventricular (LV) function include marked reduction in LV systolic and diastolic pressures, leading to reverse LV remodeling, a normalized pressure volume relation, and myocyte recovery, with improved contractile function. At rest, the acute effects of LVAD consist of a decrease in resting left and right atrial pressures and an increase in cardiac index, vascular conductance and blood flow [4] [5] 8] . Resting hemodynamic changes occur immediately after implantation, in most cases within less than 2 days.
Virtually all LVAD recipients should be physically active. When challenged with any exercise task, the human body responds through a series of integrated changes in function that involve most, if not all, of its physiologic systems. The magnitude of these changes depends largely on the intensity and duration of the exercise sessions, the force or load used, and the body's initial level of fitness. For LVAD patients, apart from the level of their disease severity, the design itself of the device is also important. As mentioned, LVADs can be broadly categorized as displacement pulsatile or rotary continuous flow [10] . Pulsatile are volume displacement devices that operate in a full-toempty mode that automatically adjusts beat rate to changes in LV preload; the new generation LVADs incorporate continuous-flow rotary pump technology with axial configuration. Haft et al. [11] evaluated exercise performance in two groups of patients according to LVAD design: Heart-Mate (HM) XVE, a pulsatile device, vs. HM II, a continuous-flow rotary design. Briefly, the HM XVE is typically operated in a full-to-empty mode: beat rate automatically increases or decreases in response to changes in LV preload and filling rate of the pump chamber. Maximum device output is approximately 10 L/minute at a heart rate of 120 beats/minute. The HM II (Thoratec, Inc) is a continuous-flow rotary pump with an axial design: the pump has an operating RPM range of 6000 to 15000 and can generate up to 10 L/minute of flow at a pressure of ~100 mm Hg. Haft et al. showed that peak oxygen consumption (VO2) was similar for the two groups at 3 months after LVAD implantation (15.4±4.0 for HM XVE vs. 15.6±4.7 mL/kg/min. for HM II), despite significant differences in LV volume unloading: decrease in LV size, reduction in degree of mitral insufficiency, and increase in LV ejection fraction were significantly greater for the HM XVE group. These results confirmed those by Jaski et al. [12] : no differences in peak VO2 were observed between patients with two different LVAD designs, both pulsatile devices but with different mechanisms of device actuation (HM IP-pneumatic; HM VE-electrical).
The function of the native ventricle is important for the exercise physiology of LVAD. The native heart-LVAD complex responds physiologically and demonstrates a significant circulatory reserve consistent with the capability to meet demands of daily activities [13] . Jaski et al. [14] showed that patients with an asynchronous fill to empty mode LVAD can increase cardiac output (CO) by increasing rate with increased venous return: LVAD stroke volume was set and remained essentially constant, much as in normal hearts, where stroke volume changes only slightly to achieve the increased CO during vigorous exercise. Most if not all of the systemic CO at rest was contributed by the LVAD, and minimal to no aortic valve opening or left ventricular outflow tract ejection was documented: on the contrary, during dynamic exercise, aortic ejection was apparent and total systemic CO exceeded the LVAD output. Therefore, although the LVAD is designed to function parallel, in effect it works in series with the left ventricle.
Summary remarks: in LVAD recipients, exercise is a complex, composite integration between the physiologic systems (altered by the disease) and the device function [13] [14] [15] : exercise performance is the result of numerous adaptive mechanisms that involve the native LV, the right ventricle (RV), the pulmonary hemodynamic, the overall and muscle conditioning, and the device. In addition, several non hemodynamic-or device-related factors, such as duration of HF symptoms, preoperative length of hospital and intensive care unit stay, preoperative serum prealbumin, duration of postoperative recovery, and medical therapy, may all affect exercise tolerance as well. Of note, dissimilarities in LVAD designs seem to play a marginal role.
Early mobilization
Ideally, LVAD recipients should initiate an exercise program as soon as possible [16] . The ultimate goals of early mobilization are to prevent postoperative complications due to bed rest, minimize loss of mobility, maximize independence, and facilitate weaning from the ventilator [16] [17] . As a general rule, early mobilization should take into account the pre-LVAD condition: some patients with acute hemodynamic instability and/or recent HF may already be familiar with exercise modes and training sessions, and able to reinitiate the training program promptly with minimal reeducation. On the other hand, patients who were dependent on long-term inotropic support therapy or who had signs or symptoms of deconditioning might need a slower, more cautious approach. Nevertheless, in the immediate post-LVAD implantation period, a series of sequential steps needs to be followed [17] : the patient should first be evaluated by a physical therapist ( Table 1 ) and an individualized treatment plan of physical therapy defined ( Table 2 ). Since physical therapy interventions are dependent on overall medical condition and hemodynamic stability, complications (e.g. infections, RV failure, bleeding, ventricular arrhythmia, anorexia and neurological impediments) can postpone the start of physical therapy or delay its course.
Therefore, LVAD patients should be closely monitored for any signs of exercise-related complications or LVAD dysfunction alarms (Table 3) . If such occur, the physical therapy session should be interrupted, and re-initiated when clinical condition and/or device operability are restored. An open approach is recommended, and the physical therapist should liaise closely with physicians, nurses, respiratory therapists and psychologists to ensure efficient and safe mobilization.
Exercise should consist mainly of passive and active range of motion accompanied by incentive spirometry to facilitate pulmonary toilet. Once out of bed in a chair, leg raising and hip girdle exercises are useful as a preparation to transfer weight from sitting to standing. Once the patient is able to stand, ambulation should be initiated, initially in the patient's room, progressing later to the ward. Later on, a set routine consisting of bicycle, treadmill, upper body ergometry and free weights can be carried out safely in the controlled intensive rehabilitation setting. Review of prior level of function.
Mental status, and cognitive ability.
Vital signs, screening for cardiovascular instability.
Medications, i.e. need for continuous or intermittent infusions (inotropic drugs).
Ventilator settings or oxygen requirements.
Surgical wound, and skin integrity.
Range of motion, coordination, balance, strength, endurance. • Breathing.
Bed mobility activities • Sitting on edge of bed, in association with exercises, trunk control.
• Turning side to side.
Transfers from bed to • Stretcher-chair.
• Chair.
• Commode.
Gait
• Pre-gait activities: weight shifting, stepping in place and sideways.
• Gait training with rolling walker. Hypotension associated with fainting, dizziness, or diaphoresis.
Supine resting heart rate >100 beats per minute.
Severe, intolerable dyspnea.
Saturation less than 90% on supplemental oxygen.
Significant chest pain or discomfort.
Extreme fatigue or claudicatio.
Request of patient to stop. > 1.8 Kg increase in body mass over previous 1 to 3 days.
Complex ventricular arrhythmia at rest or appearing with exertion.
modalities based on the current literature [18] , to be carried out in a 6-week rehabilitation program. The frequency of sessions is once a day, 6-7 days per week, with a duration varying from 15 minutes to 1 hour, as tolerated.
Summary remarks: as is often the case for cardiovascular diseases, early mobilization is recommended; however the severity and heterogeneity of clinical manifestations, differences in medical prescriptions and concurrent complications preclude any standardization. Modalities of interventions, timing and duration of mobilization differ according to the individual patient, and cannot be generalized.
Exercise performance
The poor exercise performance and quality of life (QoL) scores despite optimal medical and electrical therapies, including cardiac resynchronization therapy when appropriate, highlight the limitations of currently utilized treatments for patients with end-stage HF. Thus, a critical therapeutic goal is to enhance patients' QoL and functional capabilities. LVADs significantly affect NYHA class status, QoL, peak aerobic capacity and submaximal exercise tolerance. An early and sustained clinically meaningful improvement in NYHA status, QoL and distance at the 6-minute walk (6MWD) test has been clearly demonstrated [9, 16, [19] [20] [21] [22] . In 103 patients, with pulsatile or continuous flow HM, mean 6MWD was 393±290 meters, approaching the lower range for patients without cardiovascular disease (400 meters), while, as regards QoL, the mean Minnesota Living with Heart Failure Questionnaire (MLHFQ) score was 35±31, which correlates with NYHA Class I to II: of note, no differences in 6MDW and QoL were observed if patients were stratified by LVAD type.
A substantial increase in peak oxygen consumption (VO2) has been reported [22] [23] [24] within a few months after VAD implantation. A range of peak VO2 from 14 to 24 ml/kg/min has been described; however, across studies, the work load of most of LVAD patients remains sub-optimal, i.e. about 50% to 60% of what is predicted for a given age and gender [13] .
Exercise capacity post-LVAD implantation has been compared to that of advanced HF patients and HT recipients. Peak VO2 of LVAD (TCI HM, Thermo Cardiosystems, Inc) patients was significantly greater than that of severe HF patients, with a mean peak VO2 of 12±3.0 mL/kg/min. [23] : since medical treatment of LVAD patients was minimal, it was claimed that the level of exercise performance was due almost entirely to the device therapy. Importantly, although LVAD patients showed a significantly greater CO at rest and peak exercise (LVAD output increased from ~5 L/min at rest to 11.2-11.4 L/min at peak exercise), pulmonary pressures rose significantly with exercise both in HF patients and LVAD recipients. However, even though mean pulmonary artery pressure and pulmonary capillary wedge pressure were significantly lower in the LVAD patients at peak exercise [23] , the slope of minute ventilation vs. carbon dioxide production (VE/CO2 slope) was similar between the two groups, suggesting that the relief of pulmonary hypertension achieved with LVAD therapy had no impact on the ventilatory response to exercise. This finding is consistent with the observation that acute vasodilation does not affect the ventilatory response in patients with chronic HF [25] .
LAVD patients had a lower peak VO2, peak predicted VO2, and a shorter treadmill exercise duration 1 to 3 months after implantation compared to a similar time post-HT [12] : peak VO2 correlated with peak LVAD rate and output. Kugler et al. [22] showed that physical exercise tolerance increased in both the HT and LVAD groups, a result most likely attributable to the benefits of the surgical procedure; however, both groups had sub-optimal exercise tolerance despite optimal treatment. After adjusting for age, gender and BMI, the LVAD group had a lower exercise tolerance compared to the HT group [22] . De Jonge et al. [24] evaluated exercise performance, with a sequential analysis, in two small LVAD and HT groups: in the first group, exercise performance was studied 8 and 12 weeks after LVAD implantation, while, in the second group, exercise capacity was evaluated in patients who underwent, first, LVAD implantation and then HT: exercise testing was performed 12 weeks after each procedure. All patients (first and second group) were mobilized at an early stage and participated in an intensive, supervised rehabilitation program based on dynamic exercise, strength and endurance training. In the first group, a significant increase in peak VO2 (from 21.3±3.8 to 24.2±4.8 ml/kg/min) accompanied by a significant decrease in VE/VCO2 (39.4±10.1 to 36.3±8.2) was observed at 8 weeks. In the second group, similar peak VO2, VO2 at the anaerobic threshold and VE/VCO2 values were observed 12 weeks after LAVD and after HT.
Summary remarks: in LVAD recipients, functional capacity is considerably improved compared with the pre-implantation moribund condition, and longer assist times may result in an even better exercise performance. Functional capacity can diverge because of different postoperative care and convalescence, but, apart from the limitations imposed by the operating console and the drive line, exercise capacity and daily routine activities are expected to be comparable to those of HT patients, and superior to those of advanced HF ones. Nonetheless, even though exercise testing cannot be performed in some LVAD recipients because of critical illness and complications, and hence the evaluation of only the "happy" survivors or those spared from severe comorbidity might result in an overestimation of true exercise tolerance, the exercise performance remains sub-optimal. This suggests a need not only for longterm exercise rehabilitation programs with targeted interventions on physical and psychosocial functioning, but also a modification of focus from survival to improved coping with illness-related requirements.
Exercise training
As regards exercise training (ET), assessment in LVAD recipients is scant. Data on content, setting, duration of the sessions and safety are vague, and consequently it is unclear how progressive long-term exercise programs should be set up. Even if, up to now, only anecdotal and case reports have been reported, a formal exercise training, usually in the form of progressive ambulation, bicycle, or treadmill exercise, should be started after hemodynamic stability is achieved. In addition, the basic principles of exercise prescription (frequency, intensity, duration, and mode) are applicable for LVAD recipients, as well [18] . Mettauer et al. [26] performed ET in a single patient, 3 weeks after LVAD (HeartMate 1000 IP) implantation. ET consisted of 20-30 min of constant rate stationary bicycle exercise daily, with the work rate set to obtain 50% of the maximal heart rate increase recorded during the incremental exercise test: VO2 increased by 64% at peak exercise and by 56% at the anaerobic threshold after 6 weeks of ET. Of note, further LV unloading, and increased RV load at peak exercise, leading to a decreased RV ejection fraction was observed after ET: finally, neuro-hormonal drive decreased for a given work load. Makita et al. [27] measured the anaerobic threshold levels during cardiopulmonary exercise tests in 9 LVAD patients. A training program of 10-30 min of bicycle exercise at the anaerobic threshold level 2-3 times a week plus walking in the ward on other days led to a significant increase in peak work rate. De Jonge et al. [24] proposed an interval training program for LVAD recipients: initially, the training regimen consisted of 2 to 6 min of low-level activities alternated with 1 to 2 min of rest. Training included sessions on the bicycle and treadmill, as well as with the rowing machine. Gradually, intensity was adjusted according to the level of perceived exertion (2 to 4 corresponding to "light" to "somewhat hard") on the Borg scale of 0 to 10, with exertional dyspnea not exceeding 2 on a dyspnea scale of 0 to 4. Duration of exercise was progressively increased to 20 to 40 min/day three to five times a week. In addition, strength and endurance training of local muscle groups was performed. Unfortunately, tolerability and acceptability of this intensive post-operative exercise rehabilitation program were not reported.
Summary remarks: exercise training in LVAD is in its infancy. Although data are rapidly accumulating, several questions remain unsolved and the interpretation of LVAD adaptation to exercise sessions is complex. For instance, in the same patient, at the beginning of the exercise session one might observe a change in pump flow volume as a result of the change in posture, while the device output thereafter remains steady. Changes in pump flow might be either symptomatic or asymptomatic. In addition, since both the LVAD output and the patient's native LV output contribute to the total output during exercise, and individual differences in physiologic and LVAD responses to exercise have been observed, an individual-based regulation of LVAD function should be considered to maximize the effectiveness of the device for an efficient and safe ET program.
Conclusions and future directions
As the impact of device therapy continues to increase and permeate the medical community, it is imperative to disseminate knowledge and experiences. LVAD recipients show a significant exercise improvement after implantation, but their functional capacity remains sub-optimal. There is room for improvement, and there is an astounding opportunity for cardiac rehabilitation to determine the most effective ways to promote and standardize specific exercise regimes, targeted at both physical and psychosocial functioning, and to motivate LVAD patients to practise a level of physical activity that can benefit their health and well-being. The challenge that lies ahead is formidable.
